![spacer](https://webarchive.library.unt.edu/eot2008/20090119044442im_/http://www.ehponline.org/siteimages/transpixel.gif) |
| ![spacer](https://webarchive.library.unt.edu/eot2008/20090119044442im_/http://www.ehponline.org/siteimages/transpixel.gif) |
Spheres of Influence
|
Botanical Supplements: Weeding Out the Health Risks David A. Taylor Abstract Over the past decade, the marketplace has seen the rising popularity of botanical dietary supplements. At the same time, the U.S. Food and Drug Administration (FDA) has seen a rising need for better regulation of such products. Reports have mounted describing adverse health effects from certain products ; variable quality, efficacy, and content of products on store shelves ; and questionable advertising claims made on their behalf. As part of its mandate to regulate botanical supplements, the FDA has undergone reorganizations to help it better manage the myriad number of products within this class of products. And the NIH has increased its budgets for research to eliminate the huge gaps in the data on botanical dietary supplements. The full version of this article is available for free in HTML or PDF formats. |
|
|
![spacer](https://webarchive.library.unt.edu/eot2008/20090119044442im_/http://www.ehponline.org/siteimages/transpixel.gif) |
|